Protalix BioTherapeutics
PLX
PLX
45 hedge funds and large institutions have $8.4M invested in Protalix BioTherapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
8
Closed
7
Calls
$98K
Puts
$10K
Net Calls
+$88K
Net Calls Change
+$63K
Top Buyers
1 |
1
Northern Trust
Chicago,
Illinois
|
$1.38M |
2 |
2
Renaissance Technologies
New York
|
$2.1M |
3 |
3
Morgan Stanley
New York
|
$320K |
4 |
![]()
4
Marshall Wace
London,
United Kingdom
|
$192K |
5 |
5
Jane Street
New York
|
$214K |